Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions Abraham J. WilhelmJeroen C. G. den BurgerEleonora L. Swart Review Article Open access 10 September 2014 Pages: 961 - 973
Clinical Pharmacokinetics and Pharmacodynamics of the Novel SGLT2 Inhibitor Ipragliflozin Takeshi KadokuraWenhui ZhangRonald Smulders Review Article 15 October 2014 Pages: 975 - 988
Protecting the Fetus Against HIV Infection: A Systematic Review of Placental Transfer of Antiretrovirals Shelley A. McCormackBrookie M. Best Systematic Review 16 September 2014 Pages: 989 - 1004
First Dose in Neonates: Are Juvenile Mice, Adults and In Vitro–In Silico Data Predictive of Neonatal Pharmacokinetics of Fluconazole Wei ZhaoChantal Le GuellecEvelyne Jacqz-Aigrain Original Research Article 26 August 2014 Pages: 1005 - 1018
Population Pharmacokinetics Analysis of Vigabatrin in Adults and Children with Epilepsy and Children with Infantile Spasms Jace C. NielsenKenneth G. KowalskiDwain Tolbert Original Research Article 30 August 2014 Pages: 1019 - 1031
Pharmacokinetics, Pharmacodynamics, and Tolerability of Single Ascending Doses of RCT-18 in Chinese Patients with Rheumatoid Arthritis Xia ChenYong HouPei Hu Original Research Article 02 September 2014 Pages: 1033 - 1044
Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept Miriam G. MooijEsther van DuijnSaskia N. de Wildt Short Communication Open access 17 September 2014 Pages: 1045 - 1051
Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions Karen RobijnsRemco A. KosterDaan J. Touw Letter to the Editor 14 October 2014 Pages: 1053 - 1053
Hepatotoxicity of Alogliptin Elizabeth BarbehennSammy AlmashatSidney Wolfe Letter to the Editor 22 October 2014 Pages: 1055 - 1056
Alogliptin: Concern About Hepatotoxicity? André J. Scheen Letter to the Editor 22 October 2014 Pages: 1057 - 1059
Erratum to: Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus André J. Scheen Erratum 22 October 2014 Pages: 1061 - 1061
Erratum to: Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine Susanne JohanssonJessica ReadPaul Martin Erratum 26 September 2014 Pages: 1063 - 1063